3)- Milind Y Desai, Adel Hajj Ali. Mavacamten, an Alternative to Septal Reduction Therapy for Patients with Hypertrophic Cardiomyopathy.Heart international. 2023, 17 (1): 2-4
4)- Adam Ioannou, Marianna Fontana, Julian D Gillmore. Patisiran for the Treatment of Transthyretin-mediated Amyloidosis with Cardiomyopathy.Heart international. 2023, 17 (1): 27-35
5)- Wayne L Miller. Measurement of Blood Volume in Patients with Heart Failure: Clinical Relevance, Surrogates, Historical Background and Contemporary Methodology.Heart international. 2023, 17 (1): 36-43
6)- Muhammad Junaid Ahsan, Azka Latif, Soban Ahmad, Claire Willman, Noman Lateef, Muhammad Asim Shabbir, Mohammad Zoraiz Ahsan, Amman Yousaf, Maria Riasat, Magdi Ghali, Jolanta Siller-Matula, Yeongjin Gwon, Mamas A Mamas, Emmanouil S Brilakis, J Dawn Abbott, Deepak L Bhatt, Poonam Velagapudi. Outcomes of Prediabetes Compared with Normoglycaemia and Diabetes Mellitus in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis.Heart international. 2023, 17 (1): 45-53
7)- Abigail Latimer, Christopher E Knoepke, Roger Winters. Integrating Palliative Care into the Management of Heart Failure with Reduced Ejection Fraction: A Practice Pearl.Heart international. 2023, 17 (1): 5-7